Youre going to help your kidneys, and youre going to help your liver. Several mechanisms contribute to the benefits from GLP-1s, including antiatherosclerotic effects, blood pressure reduction, decreased platelet aggregation and cognitive impact, plus a metabolic dysfunctionassociated steatohepatitis (MASH) indication for patients with fatty liver disease
Guo C, Sun L, Chen X, Zhang D
The FDA is unequivocal that "retatrutide and cagrilintide cannot be used in compounding under federal law." "These are not components of FDA-approved drugs and have not been found safe and effective for any condition," the agency said in drug safety information posted online
A 2023 study published in JAMA Ophthalmology examined over 16,000 patients and found a small but statistically significant increased risk of certain retinal complications in those prescribed semaglutide compared to other diabetes medications
Monthly Injections: The holy grail for many would be a once-a-month injection